A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD

by | Jul 2, 2026 | Clinical Trials | 0 comments

​ Conditions: Attention Deficit Hyperactivity Disorder; Attention-Deficit / Hyperactivity Disorder; ADHD

Interventions: Drug: AK-D101; Drug: Placebo

Sponsors: Alvogen Korea

Not yet recruiting Conditions: Attention Deficit Hyperactivity Disorder; Attention-Deficit / Hyperactivity Disorder; ADHD
Interventions: Drug: AK-D101; Drug: Placebo
Sponsors: Alvogen Korea
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *